7:30 AM - 8:20 AM

Registration & Refreshments

Show more
8:20 AM - 8:30 AM

Chair’s Opening Remarks

Olaf Queckenberg, Head of Chemical & Pharmaceutical Development, Bayer AG
8:30 AM - 9:10 AM

Small Molecules

Transforming the Small Molecule to Medicine Product Design Process?

Brian Henry, Vice President Drug Product Design, Pfizer
Show more
9:15 AM - 9:50 AM - Case Studies

Small Molecules

Solvent-Induced Phase Separation in Amorphous Solid Dispersions

Gabriele Sadowski, Faculty Head, TU Dortmund University
Show more

Biologics

Fixed Dose mAb Combinations: A recent case study highlighting CMC development challenges and strategies

Tarik Khan, Group Leader, Late-Stage Pharmaceutical and Processing Development, Roche
Show more

Technology & Innovation

Implementation of QbD based Control Strategy during Drug Product Continuous Manufacturing

Frantz Elbaz, Formulator Project Leader and Pharm Development QBD Network Leader, Novartis
Show more

Device Development

Application of Decision Analytics to Device Selection and Development

Martin McLoughlin, Head of Device Development, Bristol-Myers Squibb
Show more
9:50 AM - 10:25 AM - Case Studies

Small Molecules

Biopharmaceutics Risk Assessment During Formulation and Clinical Development

Filippos Kesisoglou, Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences, MSD
Show more

Biologics

Introduction on “Next Generation Biologics

Carsten Olbrich, Product Quality Steward Eylea and Anetumab Ravstantine , Bayer
Show more

Technology & Innovation

Manufacturing the Future: a strategic approach to Product and Process development by Continuous Manufacturing

Giustino Di Pretoro, Associate Director, Johnson & Johnson
Show more

Device Development

Left to Our Own Devices: Design Control and Risk Management Strategies for Combination Products

Richard Wedge, Compliance Lead , Pfizer Ltd
Show more
10:25 AM - 11:25 AM

iSolve & Break

11:29 AM - 11:29 AM - Case Studies

Technology & Innovation

Combining the Best of Two Worlds: Using High Throughput Physico-Chemical Testing & Biorelevance Assays in Biotherapeutics Development

Sabine Eichling, Senior Scientist II, NBE High-Throughput and Advanced Formulation Sciences, Abbvie
Show more
11:30 AM - 12:05 PM - Case Studies

Small Molecules

Microenvironmental pH Modulation – An Effective Tool in Enhancing Dissolution and Oral Absorption of Solid Dosage Forms

Helen Hao Hou, Scientist Small Molecule Pharmaceutical Sciences , Genentech
Show more

Biologics

A Thermodynamic Approach to Explore Excipient Mixtures and Novel Excipients in High Concentration Protein Formulations

Christoph Brandenbusch, Associate Professor, University of Dortmund
Show more

Technology & Innovation

Facilitating meaningful differentiation of products by establishing a culture of innovation

Scott Ariagno, Head, Infusion and Reconstitution Systems / Director, Device Development and External Manufacturing, Shire
Show more

Device Development

Risk Management and Formative Human Factor studies

Muriel Didier, Human Factors Team Head, Novartis
Show more
12:10 PM - 12:45 PM - Solution Spotlights

Small Molecules

Solution Spotlight with Adare Pharmaceuticals How-to Use Oral Drug Delivery Technology Innovatively

Dr. Jin Wang-Lai, Senior Director - Pharmaceutical Development, Adare Pharma
Show more

Technology & Innovation

Solution Spotlight with Losan Pharma Efficient and predictive screening tools –facilitation of the development of nanoparticulate formulations for oral, parenteral and topical applications

Dr. Matthias Rischer, Director Drug Delivery & Innovation Projects , Losan Pharma
Show more

Device Development

Solution Spotlight with Datwyler Enabling device innovation through component customisation

Carina Van Eester, Platform leader PFS and cartridges, Datwyler Sealing Solutions
Show more
12:10 PM - 12:45 PM - Case Studies

Biologics

Solution Spotlight with Pfanstiehl Understanding Sucrose: Matching Sucrose Quality to Functional Need

Dr. Christian Lotz, Director, Business Development, Pfanstiehl
Show more
12:45 PM - 1:45 PM

Networking Lunch

Wolfgang Beier, CSO, Leon-nanodrugs
Show more
1:45 PM - 2:20 PM - Case Studies

Small Molecules

Differentiating Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane

Bernard van Eerdenbrugh, Pre-clinical Formulation Expert, Chem. & Pharmaceut. Profiling Technical R&D, Novartis
Show more

Biologics

Protein aggregation in multidose parenteral formulations: challenges during formulation development

Kathrin Spielberger, Lab Head Formulation Development, Sanofi
Show more

Device Development

Who moved my Device?” – a talk on working within the changing regulatory landscape around combination and medical devices.

Bjørg Hunter, Device Engineering Manager, GlaxoSmithKline
Show more
2:25 PM - 3:00 PM - Solution Spotlights

Small Molecules

Solution Spotlight with Grace New Insights in Mesoporous Silica Drug Delivery: Scalable Processing and Solvent Free Techniques

Fred Monsuur, TCS and Business Development Manager Excipients, W.R. Grace
Show more

Biologics

Solution Spotlight with Unchained Labs Rip through formulation prep with a Junior, a Lunatic and an Uncle

Joe Barco, Sr. Director Marketing, Unchained Labs
Show more

Device Development

Solution Spotlight with Enable Injections Enable Injections: A Drug Delivery Technology to Enable your Portfolio

Mike Hooven, President and CEO, Enable Injections, Inc.
Show more
2:25 PM - 3:00 PM

Solution Spotlight with LTS Lohman

3:05 PM - 4:00 PM

iSolve & Networking Refreshments

4:05 PM - 4:35 PM - Case Studies

Small Molecules

The unmet need of biodegradable parenteral controlled release DDS: concept, performance and perspectives

Prof. Dr. Karsten Mäder, Head of Pharmaceutical Technology, Martin Luther University Halle-Wittenberg
Show more

Biologics

High-concentration protein formulations: How high is high? Some reflections on feasibility

Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim
Show more

Technology & Innovation

Novel Developments in the Formulation of Amorphous Solid Dispersions

Thomas Rades, Chair Pharmaceutical Sciences, University of Copenhagen
Show more

Device Development

Risk Management and Formative Human Factor

Muriel Didier, Human Factors Team Head, Novartis
Show more
4:40 PM - 5:15 PM - Case Studies

Small Molecules

Absorption Modelling in Regulatory Context – from IVIVC to PBPK

Bertil Abrahamsson, Senior Principal Scientist, Astrazeneca
Show more

Biologics

Protein-based nanoparticles for drug delivery purposes

Juan Irache, Professor of Pharmaceutical Technology, University of Navarra
Show more

Device Development

Bridging between device types during clinical development

Show more
8:05 AM - 8:35 AM

Registration & Refreshments

Show more
8:35 AM - 8:40 AM

Chair’s Opening Remarks

Olaf Queckenberg, Head of Chemical & Pharmaceutical Development, Bayer AG
8:40 AM - 9:15 AM - Keynote

Technology & Innovation

Jet milling Industrialization of sticky Active Pharmaceutical Ingredient using QbD approach

Mostafa Nakach, Head of Pharmaceutical engineering-Paris, Sanofi
Show more
9:20 AM - 9:50 AM - Case Studies

Small Molecules

Leveraging prediction tools to accelerate product development

Jatin Patel, Head – Oral Product Design & Development, Bristol-Myers Squibb
Show more

Biologics

The Power of Predictive Stability Modelling in Drug Product Development

Ellen Verheyen, Senior scientist – Stability Expert, Janssen
Show more

Technology & Innovation

Fill and Finish processing of Biotech products

Jean-René Authelin, Global director of Pharmaceutical Engineering , Sanofi
Show more

Device Development

Panel Discussion: Challenges and opportunities in combination product design, development and use

Bastiaan de Leeuw, Head of Business Development – Drug Delivery, Cambridge Design Partnership
Muriel Didier, Human Factors Team Head, Novartis
Show more
9:50 AM - 10:50 AM

iSolve & Networking Break

10:50 AM - 11:25 AM - Case Studies

Small Molecules

Biopharmaceutics as Catalyst for Quality by Design

Jerome Mantanus, Head of Formulation and Process Characterisation, UCB
Show more

Biologics

Formulation Design of Smaller Proteins and Insulin for Multiple Injection Dosing and/or Infusion

Svend Ludvigsen, Senior Scientific Director, Novo Nordisk
Show more

Technology & Innovation

Predictive strategies for physical and biopharmaceutical behaviour in early phase development: from crystallization to taste

Professor Duncan Craig, Director, Chair in Drug Delivery, UCL School of Pharmacy
Show more

Device Development

Trends and challenges in inhaled drug delivery transforming respiratory drug portfolios

Gunilla Petersson, Science & Innovation Director, Astrazeneca Sweden
Show more
11:30 AM - 12:05 PM - Solution Spotlights

Small Molecules

Solution Spotlight with Hovione Amorphous Solid dispersions. What’s next?

Márcio Temtem, Associate Director for Drug Product Development, Hovione
Show more

Biologics

Solution Spotlight with Albumedix Formulation of Hard-to-Stabilize Biopharmaceuticals

Eleonora Cerasoli, Senior Research Scientist, Albumedix
Show more

Device Development

Solution Spotlight with Cambridge Design Partnership

Tom Lawrie-Fussey, Digital Services Specialist, Cambridge Design Partnership
Show more
11:30 AM - 12:05 PM - Case Studies

Technology & Innovation

Solution Spotlight with DFE Pharma Introduction of a new highly compactable, water soluble, lactose based functional excipient (SuperTab® 40LL).

Dr Bastiaan Dickhoff, Product Application Specialist OSD , DFE Pharma
12:10 PM - 12:45 PM - Case Studies

Small Molecules

Oral delivery of hydrophobic drugs using mixed micelles

Rene Van Nostrum, Associate Professor, Utrecht University
Show more

Biologics

Oral Peptide Technologies Progressing in the Clinic: Addressing Challenges to Bring New Products to the Market

Joel Richard, Senior Vice President, Peptides, Ipsen
Show more

Technology & Innovation

Absorption Modelling in Regulatory Context – from IVIVC to PBPK

Bertil Abrahamsson, Senior Principal Scientist, Astrazeneca
Show more

Device Development

Tissue Specific Delivery Using Caveolae Technology Improves Drug Efficacy

Ruchi Gupta, Scientist I, MedImmune
12:45 PM - 1:45 PM

Networking Lunch

Show more
1:45 PM - 2:20 PM - Case Studies

Small Molecules

Early “Developability” Assessment, Key to Success in Development Phases

Philippe Lienard, CMC Discovery Coordinator, Sanofi
Show more

Biologics

Mucoadhesive polymers: product developments and future trends

Andreas Bernkop-Schnürch, Professor, University of Innsbruck
Show more

Technology & Innovation

Microneedles: From Basic Research to a Drug Product

Yash Kapoor, Associate Principal Scientist, MSD
Show more

Device Development

Dry Powder Inhaler (DPI) products: From small to industrial scale at Chiesi

Isabel Sequeira Lopes, Senior Formulation Scientist/Project Coordinator, Chiesi
Show more
2:25 PM - 3:00 PM - Solution Spotlights

Small Molecules

Solution Spotlight with Dow

Dr. Meinolf Brackhagen, Senior TS&D Scientist / Pharma, Dow Chemical Company

Biologics

Solution Spotlight Revox Sterilization Solutions Sterilization Solutions for Todays Drug/Device Combinations

Herve Barre, Chef de projet Sterilisation WW, Industrial Engineer , BD Medical Pharmaceutical Systems
James A. McCoy, Staff Scientist, Head of Sterilization R&D/Innovation Center, BD Medical Pharmaceutical Systems
Show more

Technology & Innovation

Solution Spotlight with Lonza

Prof. Dr. Sven Stegemann, Director Pharmaceutical Business Development, Lonza
Show more

Device Development

Solution Spotlight with Portal Instruments Transforming the Patient Experience with a Novel Needle Free Drug Delivery Device

Patrick Anquetil, CEO, Portal Instruments
Show more
3:40 PM - 4:15 PM - Case Studies

Small Molecules

User Friendly Medicines

Clive Wilson, J.P. Professor of Pharmaceutics, University of Strathclyde
Show more

Biologics

Thermal Stabilization of Freezing Sensitive Adjuvanted Vaccine Formulations Through Spray Drying

Olivier Brass, Formulation Scientist, Sanofi Pasteur
Show more

Technology & Innovation

Novel approaches for efficient topical delivery of small - and biomacromolecules

Prof. Dr. Sarah Hedtrich, Professor, Freie Universitat Berlin
Show more

Device Development

Predictive tools for rational development of dry powder inhalation (DPI) products and process

Dr. Amrit Paudel, Assistant Professor Institute of Process and Particle Engineering, Graz University of Technology
Show more
4:20 PM - 4:55 PM - Case Studies

Small Molecules

Solution Spotlight with Patheon Scalability, a Topic to Consider in Early Development?

Kaspar van den Dries, Senior Director and Principle Scientist, Solid Dose Development, Patheon, Part of Thermo Fisher Scientific
Show more

Biologics

Solution Spotlight biopharma Group Freeze Drying Protein Formulations: A Journey from Challenge to Opportunity

Dr. Roberto Castangia, Global Sales Manager, biopharma group

Device Development

Solution Spotlight with Medical Device Usability Ltd Auto injectors – an Insight into User Needs

Richard Featherstone, Managing Director, Medical Device Usability Ltd
Show more
4:20 PM - 4:55 PM - Solution Spotlights

Technology & Innovation

Solution Spotlight with ADM SIO Tackling the Challenge of Natural Variability Related to Plant-Based Pharmaceutical Ingredients

Stéphanie Bureau, R&D Director, ADM-SIO
Show more
5:00 PM - 5:45 PM - Panel Discussion

Technology & Innovation

Panel Discussion: How Big Data and Artificial Intelligence can Revolutionize Pharmaceutical R&D

Olaf Queckenberg, Head of Chemical & Pharmaceutical Development, Bayer AG
Brian Henry, Vice President Drug Product Design, Pfizer
Professor Duncan Craig, Director, Chair in Drug Delivery, UCL School of Pharmacy
Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim
5:45 PM - 5:55 PM

Chair’s Closing Remarks

Olaf Queckenberg, Head of Chemical & Pharmaceutical Development, Bayer AG

Drinks Reception

8:00 AM - 8:20 AM

Registration & Refreshments

Show more
8:20 AM - 8:25 AM

Chair’s Opening Remarks

Olaf Queckenberg, Head of Chemical & Pharmaceutical Development, Bayer AG
8:30 AM - 9:05 AM - Keynote

Technology & Innovation

Smart Drug Delivery Systems: Going Inside Cells and to Individual Organelles

Vladimir P. Torchilin, Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University
9:10 AM - 9:45 AM - Case Studies

Small Molecules

Predictive Stability in Pharmaceutical Development

Helen Williams, Associate Principal Scientist, AstraZeneca
Show more

Biologics

New Approaches to Advance Therapeutic Drug Delivery across the Blood-Brain Barrier to Brain and Brain Tumours TTUHSC

Stephen Buckley, Head of Department, Absorption and Biological MS, Novo Nordisk
Show more

Technology & Innovation

Recent Advances in the Development of Ocular Drug Delivery Systems

Gregoire Schwach, Head of Drug Delivery, Pharmaceutical Development and Supplies Biologics, EU F. Hoffmann-La Roche
Show more
9:50 AM - 10:25 AM - Solution Spotlights

Small Molecules

Solution Spotlight with Quotient Sciences Accelerating development of spray dried dispersions for early phase clinical trials and beyond

Nikki Whitfield, Vice President CDMO Services, Quotient Sciences
Show more

Biologics

Solution Spotlight with Roquette Exploration of Anti-Aggregation and Protein Stabilization Properties of Novel Carbohydrates’

Sofiya Yashchuk, Technical Applications Specialist, Roquette
Show more

Technology & Innovation

Solution Spotlight with Merck KGaA

Dr. Finn Bauer, Head of Solid Formulations R&D, Merck KGaA
Show more
10:25 AM - 10:45 AM

Networking Break & Refreshments

10:45 AM - 11:20 AM - Case Studies

Small Molecules

Ensuring Age-Appropriate Medicines for Children

Hannah Batchelor, Senior Lecturer in Pharmaceutics, Formulation and Drug Delivery, University of Birmingham
Show more

Technology & Innovation

Innovative Ocular Drug Delivery Systems

Thakur Raj Singh, Senior Lecturer in Pharmaceutics, Queen's University Belfast
Show more
11:20 AM - 11:55 AM - Case Studies

Small Molecules

Suspendilicious: unveiling the marvels of lipid suspensions

Kristof Kimpe, Principal Scientist, Janssen Pharmaceutica (a division of Johnson & Johnson)
Show more

Biologics

Development of Antibody drug conjugate drug products

Daniel Schweizer, DP Project Lead TD NBE’s, Novartis
Show more

Technology & Innovation

Nucleic Acid Based Therapeutics for Cancer: Targeted Delivery Systems and In Vivo Bioimaging

Manfred Ogris, Professor Pharmaceutical Sciences, Head of the Laboratory for Macromolecular Cancer Therapeutics, Division of Clinical Pharmacy and Diagnostics Vienna University
Show more
11:55 AM - 12:30 PM - Solution Spotlights

Small Molecules

Solution Spotlight with PMC Isochem: The Multiple Functions of Vitamin E TPGS; a Solution for Your Drug Delivery Innovation?

Yves Robin, R&D Director, PMC Isochem (PMC Group)
Show more

Biologics

Solution Spotlight with Foster Innovation Twin-Screw Melt Granulation of Thermally Labile Drug: Effect of Processing Conditions

Feng Zhang, Assistant Professor, University of Texas at Austin
Show more

Technology & Innovation

Solution Spotlight with Nanoform Nanoparticle Production with Supercritical CO2

Professor Edward Hæggström, Chief Executive Officer, Nanoform
Show more
12:30 PM - 1:30 PM

Networking Lunch

1:40 PM - 2:15 PM - Case Studies

Small Molecules

Quantitative Biopharmaceutics: Use of Modelling and Simulation to Inform API and Formulation Decisions

Filippos Kesisoglou, Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences, MSD
Show more

Biologics

Bioinspired drug delivery systems

Lorenz Meinel, Chair for Drug Formulation and Delivery, Wurzburg University
Show more

Technology & Innovation

Cryopreservation of ex vivo Cell and Gene Therapies

Richard Zajicek, Head of Formulation Development, Cell and Gene Therapy Group, GSK
Show more
2:15 PM - 2:50 PM - Keynote

Small Molecules

Applying Biopharmaceutics in Global Public Health – Deworming Children More Safely

Christophe Tistaert, Senior Scientist, Janssen Belgium
Show more
2:50 PM - 3:00 PM

Chair’s Closing Remarks

Olaf Queckenberg, Head of Chemical & Pharmaceutical Development, Bayer AG